News and Trends 28 Apr 2023
ADC firm Adcentrx Therapeutics aims for clinic after $38M boost
Antibody-drug conjugate (ADC) biotech company Adcentrx Therapeutics has closed a $38 million Series A+ financing. The round was led by Eight Roads Ventures, with participation from F-Prime Capital, ABio-X, Delta…